Use of Pramehnil Tablet an Ayurvedic formulation in disease of kaphaj prameha or type 2 Diabetes

A Randomised Controlled Clinical Trial to evaluate the efficacy and safety of Pramehnil Tablet an Ayurvedic formulation in management of Kaphaj Prameha w.s.r.to type 2 Diabetes Mellitus - Nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/101591

Enrollment

Registered

2026-01-19

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E11- Type 2 diabetes mellitus

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient freshly diagnosed or already diagnosed between the age of 30 years to 70 years with HbA1c range between 6.5 to 9 also having symptoms pf type 2 DM or kaphaj prameha and willing to give consent for participation

Exclusion criteria

Exclusion criteria: Patient not willing to give consent below the age of 30 and above the age of 70 with high HbA1c more than 9 also having complication of type 2 DM like neuropathy retinopathy nephrophathy also patient of type 1 DM Pancreatitis any other serious medical condition like malignancy pregnent and lactating mothers also excluded

Design outcomes

Primary

Measure	Time frame
Change in value of HbA1CTimepoint: At the end if trial means on 90th day and 120th day	—

Secondary

Measure	Time frame
Change in symptoms on DSQ (DIABETES SYMPTOMS QUESTIONNAIRE Change in fasting & pp sugarTimepoint: On baseline,15th day,30th,45th day, 60th day, 75th day at on 90th day,120th day	—

Countries

India

Contacts

Public ContactDr. Kirti Sachdeva

M.S.Regional Ayurveda Research Institute

vaidyaakjain@gmail.com07425063398

Outcome results